electroCore (ECOR) Restructuring Costs (2019 - 2020)
electroCore's (ECOR) quarterly Restructuring Costs came in at $99606.0 in Q2 2020, down 88.28% year-on-year from $849792.0 in Q3 2019, and down 72.71% quarter-over-quarter from $365000.0 in Q1 2020.
electroCore (ECOR) Restructuring Costs (2019 - 2020) Analysis & Trends
electroCore's Restructuring Costs history runs 2 years deep, the most recent figure standing at $99606.0 for Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 99,606.00 |
| Mar 31, 2020 | 365,000.00 |
| Jun 30, 2019 | 849,792.00 |